focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,742.00
Bid: 1,742.00
Ask: 1,742.50
Change: -33.00 (-1.86%)
Spread: 0.50 (0.029%)
Open: 1,770.00
High: 1,770.00
Low: 1,740.00
Prev. Close: 1,775.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

Wed, 01st May 2024 08:57

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

A host of financial markets in mainland Europe and beyond, including Paris, Frankfurt and Shanghai, are closed for public holidays.

The FTSE 100 index rose 13.69 points, 0.2%, at 8,157.82. The FTSE 250 was up 51.07 points, 0.3%, at 20,135.86, and the AIM All-Share was up 1.36 points, 0.2%, at 764.69.

The Cboe UK 100 was up 0.2% at 814.75, the Cboe UK 250 fell 0.2% to 17,254.36, and the Cboe Small Companies was down 0.1% at 15,720.32.

In New York, the Dow Jones Industrial Average tumbled 1.5% on Tuesday. The S&P 500 lost 1.6% and the Nasdaq Composite plunged 2.0%.

In Tokyo, the Nikkei 225 ended 0.3% on Wednesday. In Sydney, the S&P/ASX 200 slumped 1.2%.

Financial markets in Shanghai and Hong Kong are closed on Wednesday. In Shanghai, they do not re-open until Monday. Financial markets are also closed in Frankfurt, Paris, Madrid and elsewhere in Europe on Wednesday.

The pound was quoted at USD1.2485 early Wednesday, down from USD1.2523 at the time of the London equities close on Tuesday. The euro stood at USD1.0660, down from USD1.0690. Against the yen, the dollar was trading at JPY157.95, up from JPY157.44.

The Fed announces its latest interest rate decision at 1900 BST. It is expected to keep rates on hold this week, with Chair Jerome Powell likely to say that the central bank is not yet confident enough to cut as inflation remains lofty.

"Mood among investors is not cheery into the Federal Reserve's latest monetary policy decision due later today. And it's understandable. The Fed must respond to a three straight month jump in inflation and probably take a step back in its plans to cut the interest rates this year. There is even a risk that the Fed drops the expectation of a rate cut in 2024," Swissquote analyst Ipek Ozkardeskaya commented.

The economic calendar for Wednesday has a UK manufacturing PMI at 0930 BST. In the afternoon, there is the US ADP jobs report at 1315 BST, before the Fed decision in the evening.

The ADP data is expected to show employment in the US private sector grew by 175,000 last month, according to FXStreet cited consensus, easing from 184,000 in March.

The official nonfarm payrolls follow on Friday, with jobs growth of 245,000 expected, easing from 303,000 in March.

Brown Brothers Harriman analysts commented: "Of note, non-farm payrolls has outperformed ADP for eight straight months."

In London, Smith & Nephew shares rose 3.5%, the best large-cap performer. The medical devices maker said first-quarter revenue rose 2.2% on a reported basis to USD1.39 billion from USD1.36 billion.

"Revenue growth in the first quarter was driven by solid performance in our Orthopaedics and Sports Medicine & ENT businesses, partially offset by some anticipated softness in Advanced Wound Management," Chief Executive Officer Deepak Nath said.

"We are confident in our outlook and look forward to all three of our business units contributing as we deliver another year of strong revenue growth."

Smith & Nephew maintained annual guidance, expecting reporting revenue growth of 4.3% to 5.3%.

GSK added 0.7% as it raised annual guidance. Shingles drug, Shingrix, was one stand-out performer in its first-quarter, but the drugmaker reported momentum across all business areas.

Haleon fell 1.9%. GSK's former consumer healthcare business backed yearly guidance, but said reported revenue was lower amid a weaker Covid season in China in the first quarter of the year compared to a year ago.

Next fell 1.0% as it reported a first-quarter that went ahead of plan, but maintained its outlook as it predicts the second-quarter will be more tepid.

In the 13 weeks to April 27, its first-quarter, full price sales rose 5.7% on-year. The outcome was ahead of guidance, with the clothing and homewares seller having predicted growth of 5%.

It still expects pretax profit to grow 4.6% in the full-year to GBP960 million.

Next added: "We are maintaining our guidance for full price sales in the first half to be up 2.5%. This implies that our sales in Q2 will be down -0.3%. We expect the sales performance in the second quarter to be weaker than the first quarter because last year benefited from particularly warm weather from late May through to the end of June."

Aston Martin shares fell 7.6%, the worst mid-cap performer as it recorded weaker results, for a first-quarter of a year it is labelling a "period of transition".

The carmaker said revenue in the first-quarter fell 10% to GBP267.7 million from GBP295.9 million a year earlier. Its pretax loss widened to GBP138.8 million from GBP74.2 million.

Executive Chair Lawrence Stroll commented: "2024 is a year of immense product transformation at Aston Martin, with the introduction of four new models to the market before the end of the year. Our first quarter performance reflects this expected period of transition, as we ceased production and delivery of our outgoing core models ahead of the ramp up in production of the new Vantage, upgraded DBX707 and our upcoming V12 flagship sports car which we've confirmed today. As part of our ongoing programme of ultra-exclusive models, we will deliver a new Special in the fourth quarter of the year."

It expects a second-quarter performance to be "broadly similar" to the first.

Edison analyst Neil Shah commented: "Looking ahead, despite the current headwinds, AML maintains its 2024 guidance and medium-term targets, with anticipated positive free cash flow generation in H2 and beyond. These results reflect a transformative phase for AML, symbolised by the impending arrival of incoming CEO Adrian Hallmark. His appointment, slated for no later than October, signals a strategic shift as the company navigates a transition away from outgoing models towards a more sustainable future."

On AIM, Trinity Exploration surged 47%. Touchstone Exploration fell 4.4%. Touchstone said it has struck an all-share deal to acquire Trinity.

The all-share agreement values the latter at GBP24.1 million. Touchstone Exploration, an oil and natural gas exploration and production active in Trinidad & Tobago, said the deal will create a "leading Trinidadian operator of scale".

It said: "The addition of Trinity's existing production portfolio, along with its exploration and development assets, will position the combined group as one of the leading independent operating companies dedicated to investing in both onshore and offshore activity to grow Trinidadian oil and gas production."

As part of the deal, Trinity shareholders will receive 1.5 new Touchstone shares for each Trinity share owned. Trinity Shareholders will own just under 20% of the combined firm. Trinity directors consider the terms of the deal to be "fair and reasonable".

Brent oil was quoted at USD85.28 a barrel on Wednesday morning London time, down from USD86.42 late Tuesday. Gold was quoted at USD2,285.55 an ounce, down from USD2,298.10.

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
Today 08:49

GSK's depemokimab asthma treatment meets endpoints in latest trials

(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.

Read more
Today 07:21

GSK reports promising results from asthma treatment trials

(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.

Read more
20 May 2024 16:11

IN BRIEF: GSK executive buys GBP20,026 worth shares

GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.

Read more
17 May 2024 15:52

London close: Stocks recoup some earlier losses

(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.

Read more
17 May 2024 11:52

LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady

(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.

Read more
17 May 2024 09:03

TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion

(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.

Read more
17 May 2024 08:56

LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends

(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.

Read more
17 May 2024 07:42

LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake

(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.

Read more
17 May 2024 07:29

GSK raises £1.25bn from sale of remaining Haleon stake

(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.

Read more
16 May 2024 17:13

TOP NEWS: GSK to sell remaining holding in spin-off Haleon

(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.

Read more
16 May 2024 17:02

GSK to sell entire 4.2% remaining stake in Haleon

(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.

Read more
16 May 2024 16:54

LONDON MARKET CLOSE: Europe struggles but record highs in New York

(Alliance News) - Large-cap European equities closed lower on Thursday, underperforming New York counterparts, which continued to push higher following Wednesday's softer US inflation data.

Read more
16 May 2024 16:53

London close: Stocks mixed as ex-divs drag on FTSE

(Sharecast News) - London stocks ended mixed on Thursday, following a flurry of corporate news and a focus on US unemployment figures.

Read more
14 May 2024 10:11

LONDON BROKER RATINGS: DB and Berenberg raise Diploma price target

(Alliance News) - the following London-listed shares received analyst recommendations Monday and Tuesday morning:

Read more
13 May 2024 09:41

LONDON BROKER RATINGS: BAE Systems and Mondi cut to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday:

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.